Literature DB >> 25628398

Intratumor molecular and phenotypic diversity in hepatocellular carcinoma.

Jean-Charles Nault1, Augusto Villanueva2.   

Abstract

Hepatocellular carcinoma is a highly heterogeneous disease both at the molecular and clinical levels. Intratumor morphologic and genetic heterogeneity adds a new level of complexity in our understanding of liver carcinogenesis, and it is likely an important determinant of primary and secondary resistance to targeted therapies. Clin Cancer Res; 21(8); 1786-8. ©2015 AACR. See related article by Friemel et al., p. 1951. ©2015 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2015        PMID: 25628398     DOI: 10.1158/1078-0432.CCR-14-2602

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  42 in total

1.  Truncated neurokinin-1 receptor is an ubiquitous antitumor target in hepatoblastoma, and its expression is independent of tumor biology and stage.

Authors:  Agnès Garnier; Matthias Ilmer; Kristina Becker; Beate Häberle; Dietrich VON Schweinitz; Roland Kappler; Michael Berger
Journal:  Oncol Lett       Date:  2015-11-20       Impact factor: 2.967

2.  MicroRNA-129-5p promotes proliferation and metastasis of hepatocellular carcinoma by regulating the BMP2 gene.

Authors:  Zengyao Liu; Jiefei Sun; Xiaochun Wang; Zhenyuan Cao
Journal:  Exp Ther Med       Date:  2021-01-25       Impact factor: 2.447

3.  m6A regulator-mediated methylation modification highlights immune infiltration patterns for predicting risk in hepatocellular carcinoma.

Authors:  Dongkai Zhou; Yizhi Wang; Wei Wei; Wei Zhou; Jin Gu; Yang Kong; Qifan Yang; Yingsheng Wu
Journal:  J Cancer Res Clin Oncol       Date:  2022-08-16       Impact factor: 4.322

4.  High Levels of DEAH-Box Helicases Relate to Poor Prognosis and Reduction of DHX9 Improves Radiosensitivity of Hepatocellular Carcinoma.

Authors:  Xi Chen; Letao Lin; Guanyu Chen; Huzheng Yan; Zhenyu Li; Meigui Xiao; Xu He; Fujun Zhang; Yanling Zhang
Journal:  Front Oncol       Date:  2022-06-22       Impact factor: 5.738

Review 5.  Tumour evolution in hepatocellular carcinoma.

Authors:  Amanda J Craig; Johann von Felden; Teresa Garcia-Lezana; Samantha Sarcognato; Augusto Villanueva
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2019-12-02       Impact factor: 46.802

6.  Cooperation Between Distinct Cancer Driver Genes Underlies Intertumor Heterogeneity in Hepatocellular Carcinoma.

Authors:  Pedro Molina-Sánchez; Marina Ruiz de Galarreta; Melissa A Yao; Katherine E Lindblad; Erin Bresnahan; Elizabeth Bitterman; Tiphaine C Martin; Troy Rubenstein; Kai Nie; Jonathan Golas; Shambhunath Choudhary; Marina Bárcena-Varela; Abdulkadir Elmas; Veronica Miguela; Ying Ding; Zhengyan Kan; Lauren Tal Grinspan; Kuan-Lin Huang; Ramon E Parsons; David J Shields; Robert A Rollins; Amaia Lujambio
Journal:  Gastroenterology       Date:  2020-08-16       Impact factor: 22.682

Review 7.  Proteoglycans in Cancer: Friends or Enemies? A Special Focus on Hepatocellular Carcinoma.

Authors:  Francesco Dituri; Gianluigi Gigante; Rosanna Scialpi; Serena Mancarella; Isabel Fabregat; Gianluigi Giannelli
Journal:  Cancers (Basel)       Date:  2022-04-09       Impact factor: 6.575

8.  Prognostic value of DNA repair based stratification of hepatocellular carcinoma.

Authors:  Zhuo Lin; Shi-Hao Xu; Hai-Qing Wang; Yi-Jing Cai; Li Ying; Mei Song; Yu-Qun Wang; Shan-Jie Du; Ke-Qing Shi; Meng-Tao Zhou
Journal:  Sci Rep       Date:  2016-05-13       Impact factor: 4.379

Review 9.  The Endless Sources of Hepatocellular Carcinoma Heterogeneity.

Authors:  Marina Barcena-Varela; Amaia Lujambio
Journal:  Cancers (Basel)       Date:  2021-05-26       Impact factor: 6.639

10.  A Positive TGF-β/c-KIT Feedback Loop Drives Tumor Progression in Advanced Primary Liver Cancer.

Authors:  Andres Rojas; Pingyu Zhang; Ying Wang; Wai Chin Foo; Nina M Muñoz; Lianchun Xiao; Jing Wang; Gregory J Gores; Mien-Chie Hung; Boris Blechacz
Journal:  Neoplasia       Date:  2016-06       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.